Ovid Therapeutics Inc (OVID)
3.15
-0.05
(-1.56%)
USD |
NASDAQ |
Apr 24, 16:00
3.175
+0.02
(+0.79%)
After-Hours: 20:00
Ovid Therapeutics Profit Margin (Quarterly): -10.82K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.82K% |
| September 30, 2023 | -10.33K% |
| June 30, 2023 | -16.54K% |
| March 31, 2023 | -20.19K% |
| December 31, 2022 | -24.86K% |
| September 30, 2022 | -107.8K% |
| June 30, 2022 |
| Date | Value |
|---|---|
| March 31, 2022 | -1.11K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 84.46% |
| December 31, 2020 | -386.3% |
| September 30, 2020 | -237.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-107.8K%
Minimum
Sep 2022
84.46%
Maximum
Mar 2021
-19.22K%
Average
-10.57K%
Median
Profit Margin (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 64.72% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.32% |
| Return on Assets | -37.18% |
| Return on Invested Capital | -47.32% |
| Operating Margin (Quarterly) | -12.85K% |
| Return on Net Operating Assets | -299.1% |